# Reference Group Trial for The ONE Study

> **NCT01656135** · PHASE4 · COMPLETED · sponsor: **University of Regensburg** · enrollment: 70 (actual)

## Conditions studied

- End-stage Renal Failure
- Kidney Graft Rejection

## Interventions

- **OTHER:** Blood drawing for immune monitoring and questionnaires

## Key facts

- **NCT ID:** NCT01656135
- **Lead sponsor:** University of Regensburg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656135, "Reference Group Trial for The ONE Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01656135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*